Enveric Biosciences logo

Enveric Biosciences

ENVB | NASDAQ
Chart Builder DCF Calculator
$1.44
-$0.07 (-4.95%)
At close: Nov 16, 2026, 4:00 PM ET
$1.44
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.95%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
19.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #994/1021 (Top 97%)

Key Statistics

Market Data

Market Cap $6.45M
1D Range
1.43 1.54
52W Range
1.27 10.33

Valuation (TTM)

PE -0.23
PB 1.13
EV/EBITDA -0.09

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target $0.00
Loading financial charts...

Profile

Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, d...

Sector Healthcare
Industry Biotechnology
Employees 6
IPO Date May 4, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.